Alexandre Mansour, Nicolas Massart, Isabelle Gouin-Thibault, Thibault Seite, Fabrice Cognasse, Amedeo Anselmi, Alessandro Parasido, Caroline Piau, Erwan Flécher, Jean-Philippe Verhoye, Nicolas Nesseler
OBJECTIVES: Despite significant improvement in patient blood management, cardiac surgery remains a high hemorrhagic risk procedure. Platelet transfusion is used commonly to treat thrombocytopenia-associated perioperative bleeding. Allogeneic platelet transfusion may induce transfusion-related immunomodulation. However, its association with postoperative healthcare-associated infections is still a matter of debate. The objective was to evaluate the impact of allogeneic platelet transfusion during cardiac surgery on postoperative healthcare-associated infection incidence...
February 24, 2024: Journal of Cardiothoracic and Vascular Anesthesia